RecruitingNCT06105411
Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
Sponsor
Peter MacCallum Cancer Centre, Australia
Enrollment
10 participants
Start Date
Dec 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This trial will demonstrate localised uptake of a radiolabelled fungal component (siderophore) in areas of known specific invasive fungal (Aspergillus) infection.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patient has provided written informed consent
- Aged 18 years or older at written informed consent
- Within 2 weeks of proven or probable or possible invasive fungal infection (IFI) diagnosis as per EORTC criteria
- Imaging consistent with invasive pulmonary aspergillosis on CT or FDG-PET/CT with lesions at least 8mm in diameter
- Patient is willing and able to comply with the protocol for the duration of the study including scheduled visits such as follow up
Exclusion Criteria2
- Women who are pregnant or lactating.
- Iron infusion within one week prior to scan
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TEST68Ga-labelled TAFC PET/CT scan
68Ga-labelled TAFC PET/CT scan (whole body)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06105411
Related Trials
Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative
NCT057507061 location
Breath Analysis for the Detection of Invasive Fungal Infections
NCT065377261 location
Usefulness of PET-CT for Invasive Fungal Infection
NCT0568859214 locations
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
NCT064983101 location
Fungal Surveillance in Bangladesh
NCT061033311 location